Article
Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar.
Scientific reports - 16 May 2016
Su Linlin, Li Xiaodong, Wu Xue, Hui Bo, Han Shichao, Gao Jianxin, Li Yan, Shi Jihong, Zhu Huayu, Zhao Bin, Hu Dahai
Abstract excerpt
Hypertrophic scar (HS) is a serious fibrotic skin condition with currently no satisfactory therapy due to undefined molecular mechanism. FAK and Src are two important non-receptor tyrosine kinases that have been indicated in HS pathogenesis. Here we found both FAK and Src were activated in HS vs. normal skin (NS), NS fibroblasts treated with TGF-β1 also exhibited FAK/Src activation. Co-immunoprecipitation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
